The retaliatory measures followed Trump's controversial move to order the withdrawal of all U.S. troops from Syria's northern border with Turkey.Politicsread more
Bloomberg could be in for a showdown with Elizabeth Warren, whether he runs or not.2020 Electionsread more
As the season kicks into gear this week, S&P 500 firms are expected to report a 4.6% earnings decline over the same period a year agoEarningsread more
"I think that may have scared the Chinese that they were going to get into a serious trade war with access to our capital markets being cut off, among other things," Michael...China Politicsread more
David Rolfe, a longtime Berkshire Hathaway shareholder and CIO at Wedgewood Partners, is fed up with Warren Buffett.Marketsread more
Bank of America says investors should still look to stocks for value rather than bonds.Investingread more
Wall Street analysts estimate GM has lost more than $1 billion due to the United Auto Workers' strike, which began Sept. 16.Autosread more
Top financial companies will mark the unofficial start of earnings season with their reports this week, and experts are offering several recommendations for trading the moves.ETF Edgeread more
The indexes traded in a tight range as investors looked ahead to the start of the earnings season while grappling with new worries over trade.Marketsread more
The union that represents Southwest Airlines pilots don't expect the grounded Boeing 737 Max to return until at least February, about a month later than the airline expects.Airlinesread more
Check out the companies making headlines in midday trading:Market Insiderread more
Founders of some of the world's top tech firms have joined scientists and Hollywood stars in search of the fountain of youth, according to a feature in the latest issue of The New Yorker.
Amazon's Jeff Bezos and PayPal co-founder Peter Thiel, for instance, have invested in start-up Unity Biotechnology, founded by a unexpectedly youthful-looking entrepreneur who hopes to "vaporize a third of human diseases in the developed world," The New Yorker reported.
"One class of investor, like Fidelity, finds my youthful appearance alarming," Unity's co-founder told The New Yorker. "Another class — the Silicon Valley type, a Peter Thiel — finds anyone who looks over forty alarming."
Oracle co-founder Larry Ellison has donated $370 million to aging research, The New Yorker said. Meanwhile Google founders Sergey Brin and Larry Page helped launch Calico, a secretive venture that's tracking mice from birth to death in hopes of finding markers for diseases like diabetes and Alzheimer's, the report said. Calico is part of Alphabet, the holding company that also owns Google.
While some venture capitalists are lured by biotech start-ups that leverage big data and machine learning, the slower pace of biological research can be disappointing to investors, experts told The New Yorker.
And even within the tech community, views vary on how long human life should be extended, and at what cost. Some believe there are biological solutions that will allow humans to remain in their bodies longer, while others foresee a future where men merge with machines.
When CNBC reported on Silicon Valley's life-extending ambitions last year, some experts were skeptical.
"The best advice is to stay as active as you can, stay connected to other people, and eat less," John Newman, assistant professor of geriatrics at the University of California, San Francisco, told CNBC. "You'd be surprised how much we have found fundamental mechanisms of aging to be involved in these simple things."
— CNBC's Josh Lipton contributed to this report